HR e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

TAMPA: Utterback named CEO at Moffitt's M2Gen subsidiary

Moffitt Cancer Center, November 30, 2009

James Utterback has been named CEO of M2Gen, a wholly owned for-profit subsidiary of Moffitt Cancer Center, effective Dec. 7. Utterback will be responsible for developing and implementing effective growth strategies, determining commercialization opportunities, and establishing and executing pharmaceutical company-funded clinical trials.